Navigation Links
CQ Forum on Biosimilar Biological Products - Wed., June 17, 2009

WASHINGTON, June 15 /PRNewswire-USNewswire/ -- Congressional Quarterly presents a 360-degree look at the "state of play" on the approval of follow-on versions of biotech drugs. This CQ Forum will include a panel discussion with industry leaders, public interest groups, and leading researchers regarding the complex structures of biologics products vs. traditional pharmaceuticals. Are generic biologics possible? Will the availability of these products save money for consumers? What is the right length of intellectual property protection?

The event will be hosted by Congressional Quarterly and sponsored by Johnson & Johnson Pharmaceutical Services, L.L.C.

Keynote speakers include: Rep. Anna Eshoo (D-CA) and Sen. Orrin Hatch (R-UT).

Frank Sesno, professor of media and public affairs at The George Washington University and host of PBS's "Planet Forward" will moderate the panel discussion.

Panelists include:

  • Alex Brill, Research Fellow, American Enterprise Institute
  • Richard F. Kingham, Partner, Covington & Burling
  • Jay P. Siegel, M.D., Chief Biotechnology Officer, Centocor
  • Ann Witt, J.D., Health Counsel to Representative to Henry Waxman
  • Gillian R. Woollett, M.A., D.Phil, Chief Scientist, Engel & Novitt, L.L.P.

To register, please visit Space is limited.

    When:      Wed., Jun. 17, 2009
               8 to 8:30 a.m. - Breakfast and conversation
               8:30 to 11:30 a.m. - Program

    Where:     B. Smith's at Union Station
               50 Massachusetts Avenue, NE
               Washington, DC 20002

SOURCE Congressional Quarterly
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Senator Arlen Specter and Richard Gephardt Headline Policy Forum on U.S. Medical Innovation, Highlight Achieving Recovery Through Discovery
2. BIOCOMs Inaugural CALAsia Forum Bridging the Pacific
3. Orange County Laser Surgeon Nissan Pilest Tapped as Keynote Speaker at Fraxel & Thermage User Forum Held at Beckman Laser Institute
4. Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry
5. Interleukin Genetics to Present at the 2009 BIO Business Forum
6. BioMS Medical to present at Alberta Economic Forum in Geneva
7. Council for American Medical Innovation Brings U.S. Leaders in Medicine, Biotechnology and Discovery Together in Chicago for Best and Brightest Forum on Medical Innovation
8. CryoLife to Present at Sidotis 13th Annual New York Emerging Growth Institutional Forum
9. aTyr Pharma to Present at ChinaBio(R) Investor Forum in Hong Kong
10. The EntreTech Forum Presents... Greening Of America - The Conversion of Bio-Agriculture, Bio-Energy, and Bio-Products to Eco-Sustainable Businesses
11. Novavax CMO to Present at Phacilitate Vaccine Forum Washington 2009
Post Your Comments:
(Date:6/23/2016)... 2016 On Wednesday, June 22, 2016, ... 0.22%; the Dow Jones Industrial Average edged 0.27% lower to ... down 0.17%. has initiated coverage on the following equities: ... (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing their ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® Inc. ... a free webinar on Performing Quality Investigations: Getting to Root Cause. ... at no charge. , Incomplete investigations are still a major concern to the ...
(Date:6/23/2016)... 22, 2016  Amgen (NASDAQ: AMGN ) ... QB3@953 life sciences incubator to accelerate the development ... laboratory space at QB3@953 was created to help high-potential ... for many early stage organizations - access to laboratory ... Amgen launched two "Amgen Golden Ticket" awards, providing each ...
(Date:6/22/2016)... 22, 2016 Cell Applications, Inc. and ... to produce up to one billion human induced ... one week. These high-quality, consistent stem cells enable ... and spend more time doing meaningful, relevant research. ... high-volume manufacturing process that produces affordable, reliable HiPSC ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- A new partnership announced today will help life ... a fraction of the time it takes today, ... insurance policies to consumers without requiring inconvenient and ... rapid testing (A1C, Cotinine and HIV) and higi,s ... pulse, BMI, and activity data) available at local ...
Breaking Biology News(10 mins):